Global Botanical and Herbal Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Publisher Name :
Date: 23-Aug-2021
No. of pages: 106

The Botanical and Herbal Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Botanical and Herbal Drug size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Botanical and Herbal Drug market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Botanical and Herbal Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

- Prescription Drug

- OTC

Market segment by Application, can be divided into

- Cardiovascular

- Tumor

- Respiratory System

- Other

Market segment by players, this report covers

- Buchang Pharmaceuticals

- China TCM

- Tsumura

- Schwabe

- Tong Ren Tang

- Jumpcan Pharmaceutical

- Guangzhou Baiyunshan Pharmaceutical

- Yunnan Baiyao

- Tasly Holding Group

- Bionorica Se

- Huarun 999

- Taiji

- Weleda

- Kwangdong

- GW Pharmaceuticals

Market segment by regions, regional analysis covers

- North America (United States, Canada, and Mexico)

- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

- South America (Brazil, Argentina, Rest of South America)

- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Botanical and Herbal Drug product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Botanical and Herbal Drug, with revenue, gross margin and global market share of Botanical and Herbal Drug from 2019 to 2021.

Chapter 3, the Botanical and Herbal Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Botanical and Herbal Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Botanical and Herbal Drug research findings and conclusion, appendix and data source.

Global Botanical and Herbal Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Botanical and Herbal Drug
1.2 Classification of Botanical and Herbal Drug by Type
1.2.1 Overview: Global Botanical and Herbal Drug Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Botanical and Herbal Drug Revenue Market Share by Type in 2020
1.2.3 Prescription Drug
1.2.4 OTC
1.3 Global Botanical and Herbal Drug Market by Application
1.3.1 Overview: Global Botanical and Herbal Drug Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Global Botanical and Herbal Drug Market Size & Forecast
1.5 Global Botanical and Herbal Drug Market Size and Forecast by Region
1.5.1 Global Botanical and Herbal Drug Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Botanical and Herbal Drug Market Size by Region, (2016-2021)
1.5.3 North America Botanical and Herbal Drug Market Size and Prospect (2016-2026)
1.5.4 Europe Botanical and Herbal Drug Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Botanical and Herbal Drug Market Size and Prospect (2016-2026)
1.5.6 South America Botanical and Herbal Drug Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Botanical and Herbal Drug Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Botanical and Herbal Drug Market Drivers
1.6.2 Botanical and Herbal Drug Market Restraints
1.6.3 Botanical and Herbal Drug Trends Analysis
2 Company Profiles
2.1 Buchang Pharmaceuticals
2.1.1 Buchang Pharmaceuticals Details
2.1.2 Buchang Pharmaceuticals Major Business
2.1.3 Buchang Pharmaceuticals Botanical and Herbal Drug Product and Solutions
2.1.4 Buchang Pharmaceuticals Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Buchang Pharmaceuticals Recent Developments and Future Plans
2.2 China TCM
2.2.1 China TCM Details
2.2.2 China TCM Major Business
2.2.3 China TCM Botanical and Herbal Drug Product and Solutions
2.2.4 China TCM Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 China TCM Recent Developments and Future Plans
2.3 Tsumura
2.3.1 Tsumura Details
2.3.2 Tsumura Major Business
2.3.3 Tsumura Botanical and Herbal Drug Product and Solutions
2.3.4 Tsumura Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Tsumura Recent Developments and Future Plans
2.4 Schwabe
2.4.1 Schwabe Details
2.4.2 Schwabe Major Business
2.4.3 Schwabe Botanical and Herbal Drug Product and Solutions
2.4.4 Schwabe Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Schwabe Recent Developments and Future Plans
2.5 Tong Ren Tang
2.5.1 Tong Ren Tang Details
2.5.2 Tong Ren Tang Major Business
2.5.3 Tong Ren Tang Botanical and Herbal Drug Product and Solutions
2.5.4 Tong Ren Tang Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Tong Ren Tang Recent Developments and Future Plans
2.6 Jumpcan Pharmaceutical
2.6.1 Jumpcan Pharmaceutical Details
2.6.2 Jumpcan Pharmaceutical Major Business
2.6.3 Jumpcan Pharmaceutical Botanical and Herbal Drug Product and Solutions
2.6.4 Jumpcan Pharmaceutical Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Jumpcan Pharmaceutical Recent Developments and Future Plans
2.7 Guangzhou Baiyunshan Pharmaceutical
2.7.1 Guangzhou Baiyunshan Pharmaceutical Details
2.7.2 Guangzhou Baiyunshan Pharmaceutical Major Business
2.7.3 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product and Solutions
2.7.4 Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
2.8 Yunnan Baiyao
2.8.1 Yunnan Baiyao Details
2.8.2 Yunnan Baiyao Major Business
2.8.3 Yunnan Baiyao Botanical and Herbal Drug Product and Solutions
2.8.4 Yunnan Baiyao Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Yunnan Baiyao Recent Developments and Future Plans
2.9 Tasly Holding Group
2.9.1 Tasly Holding Group Details
2.9.2 Tasly Holding Group Major Business
2.9.3 Tasly Holding Group Botanical and Herbal Drug Product and Solutions
2.9.4 Tasly Holding Group Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Tasly Holding Group Recent Developments and Future Plans
2.10 Bionorica Se
2.10.1 Bionorica Se Details
2.10.2 Bionorica Se Major Business
2.10.3 Bionorica Se Botanical and Herbal Drug Product and Solutions
2.10.4 Bionorica Se Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Bionorica Se Recent Developments and Future Plans
2.11 Huarun 999
2.11.1 Huarun 999 Details
2.11.2 Huarun 999 Major Business
2.11.3 Huarun 999 Botanical and Herbal Drug Product and Solutions
2.11.4 Huarun 999 Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Huarun 999 Recent Developments and Future Plans
2.12 Taiji
2.12.1 Taiji Details
2.12.2 Taiji Major Business
2.12.3 Taiji Botanical and Herbal Drug Product and Solutions
2.12.4 Taiji Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Taiji Recent Developments and Future Plans
2.13 Weleda
2.13.1 Weleda Details
2.13.2 Weleda Major Business
2.13.3 Weleda Botanical and Herbal Drug Product and Solutions
2.13.4 Weleda Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Weleda Recent Developments and Future Plans
2.14 Kwangdong
2.14.1 Kwangdong Details
2.14.2 Kwangdong Major Business
2.14.3 Kwangdong Botanical and Herbal Drug Product and Solutions
2.14.4 Kwangdong Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Kwangdong Recent Developments and Future Plans
2.15 GW Pharmaceuticals
2.15.1 GW Pharmaceuticals Details
2.15.2 GW Pharmaceuticals Major Business
2.15.3 GW Pharmaceuticals Botanical and Herbal Drug Product and Solutions
2.15.4 GW Pharmaceuticals Botanical and Herbal Drug Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 GW Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Botanical and Herbal Drug Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Botanical and Herbal Drug Players Market Share
3.2.2 Top 10 Botanical and Herbal Drug Players Market Share
3.2.3 Market Competition Trend
3.3 Botanical and Herbal Drug Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Botanical and Herbal Drug Revenue and Market Share by Type (2016-2021)
4.2 Global Botanical and Herbal Drug Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Botanical and Herbal Drug Revenue Market Share by Application (2016-2021)
5.2 Botanical and Herbal Drug Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Botanical and Herbal Drug Revenue by Type (2016-2026)
6.2 North America Botanical and Herbal Drug Revenue by Application (2016-2026)
6.3 North America Botanical and Herbal Drug Market Size by Country
6.3.1 North America Botanical and Herbal Drug Revenue by Country (2016-2026)
6.3.2 United States Botanical and Herbal Drug Market Size and Forecast (2016-2026)
6.3.3 Canada Botanical and Herbal Drug Market Size and Forecast (2016-2026)
6.3.4 Mexico Botanical and Herbal Drug Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Botanical and Herbal Drug Revenue by Type (2016-2026)
7.2 Europe Botanical and Herbal Drug Revenue by Application (2016-2026)
7.3 Europe Botanical and Herbal Drug Market Size by Country
7.3.1 Europe Botanical and Herbal Drug Revenue by Country (2016-2026)
7.3.2 Germany Botanical and Herbal Drug Market Size and Forecast (2016-2026)
7.3.3 France Botanical and Herbal Drug Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Botanical and Herbal Drug Market Size and Forecast (2016-2026)
7.3.5 Russia Botanical and Herbal Drug Market Size and Forecast (2016-2026)
7.3.6 Italy Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Botanical and Herbal Drug Revenue by Type (2016-2026)
8.2 Asia-Pacific Botanical and Herbal Drug Revenue by Application (2016-2026)
8.3 Asia-Pacific Botanical and Herbal Drug Market Size by Region
8.3.1 Asia-Pacific Botanical and Herbal Drug Revenue by Region (2016-2026)
8.3.2 China Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8.3.3 Japan Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8.3.4 South Korea Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8.3.5 India Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Botanical and Herbal Drug Market Size and Forecast (2016-2026)
8.3.7 Australia Botanical and Herbal Drug Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Botanical and Herbal Drug Revenue by Type (2016-2026)
9.2 South America Botanical and Herbal Drug Revenue by Application (2016-2026)
9.3 South America Botanical and Herbal Drug Market Size by Country
9.3.1 South America Botanical and Herbal Drug Revenue by Country (2016-2026)
9.3.2 Brazil Botanical and Herbal Drug Market Size and Forecast (2016-2026)
9.3.3 Argentina Botanical and Herbal Drug Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Botanical and Herbal Drug Revenue by Type (2016-2026)
10.2 Middle East & Africa Botanical and Herbal Drug Revenue by Application (2016-2026)
10.3 Middle East & Africa Botanical and Herbal Drug Market Size by Country
10.3.1 Middle East & Africa Botanical and Herbal Drug Revenue by Country (2016-2026)
10.3.2 Turkey Botanical and Herbal Drug Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Botanical and Herbal Drug Market Size and Forecast (2016-2026)
10.3.4 UAE Botanical and Herbal Drug Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Botanical and Herbal Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Botanical and Herbal Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Botanical and Herbal Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Botanical and Herbal Drug Revenue (USD Million) by Region (2016-2021)
Table 5. Global Botanical and Herbal Drug Revenue Market Share by Region (2021-2026)
Table 6. Buchang Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Buchang Pharmaceuticals Major Business
Table 8. Buchang Pharmaceuticals Botanical and Herbal Drug Product and Solutions
Table 9. Buchang Pharmaceuticals Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. China TCM Corporate Information, Head Office, and Major Competitors
Table 11. China TCM Major Business
Table 12. China TCM Botanical and Herbal Drug Product and Solutions
Table 13. China TCM Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Tsumura Corporate Information, Head Office, and Major Competitors
Table 15. Tsumura Major Business
Table 16. Tsumura Botanical and Herbal Drug Product and Solutions
Table 17. Tsumura Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Schwabe Corporate Information, Head Office, and Major Competitors
Table 19. Schwabe Major Business
Table 20. Schwabe Botanical and Herbal Drug Product and Solutions
Table 21. Schwabe Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Tong Ren Tang Corporate Information, Head Office, and Major Competitors
Table 23. Tong Ren Tang Major Business
Table 24. Tong Ren Tang Botanical and Herbal Drug Product and Solutions
Table 25. Tong Ren Tang Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Jumpcan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 27. Jumpcan Pharmaceutical Major Business
Table 28. Jumpcan Pharmaceutical Botanical and Herbal Drug Product and Solutions
Table 29. Jumpcan Pharmaceutical Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Guangzhou Baiyunshan Pharmaceutical Corporate Information, Head Office, and Major Competitors
Table 31. Guangzhou Baiyunshan Pharmaceutical Major Business
Table 32. Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Product and Solutions
Table 33. Guangzhou Baiyunshan Pharmaceutical Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Yunnan Baiyao Corporate Information, Head Office, and Major Competitors
Table 35. Yunnan Baiyao Major Business
Table 36. Yunnan Baiyao Botanical and Herbal Drug Product and Solutions
Table 37. Yunnan Baiyao Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Tasly Holding Group Corporate Information, Head Office, and Major Competitors
Table 39. Tasly Holding Group Major Business
Table 40. Tasly Holding Group Botanical and Herbal Drug Product and Solutions
Table 41. Tasly Holding Group Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Bionorica Se Corporate Information, Head Office, and Major Competitors
Table 43. Bionorica Se Major Business
Table 44. Bionorica Se Botanical and Herbal Drug Product and Solutions
Table 45. Bionorica Se Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Huarun 999 Corporate Information, Head Office, and Major Competitors
Table 47. Huarun 999 Major Business
Table 48. Huarun 999 Botanical and Herbal Drug Product and Solutions
Table 49. Huarun 999 Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Taiji Corporate Information, Head Office, and Major Competitors
Table 51. Taiji Major Business
Table 52. Taiji Botanical and Herbal Drug Product and Solutions
Table 53. Taiji Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Weleda Corporate Information, Head Office, and Major Competitors
Table 55. Weleda Major Business
Table 56. Weleda Botanical and Herbal Drug Product and Solutions
Table 57. Weleda Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Kwangdong Corporate Information, Head Office, and Major Competitors
Table 59. Kwangdong Major Business
Table 60. Kwangdong Botanical and Herbal Drug Product and Solutions
Table 61. Kwangdong Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. GW Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 63. GW Pharmaceuticals Major Business
Table 64. GW Pharmaceuticals Botanical and Herbal Drug Product and Solutions
Table 65. GW Pharmaceuticals Botanical and Herbal Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Global Botanical and Herbal Drug Revenue (USD Million) by Players (2019-2021)
Table 67. Global Botanical and Herbal Drug Revenue Share by Players (2019-2021)
Table 68. Breakdown of Botanical and Herbal Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Botanical and Herbal Drug Players Head Office, Products and Services Provided
Table 70. Botanical and Herbal Drug Mergers & Acquisitions in the Past Five Years
Table 71. Botanical and Herbal Drug New Entrants and Expansion Plans
Table 72. Global Botanical and Herbal Drug Revenue (USD Million) by Type (2016-2021)
Table 73. Global Botanical and Herbal Drug Revenue Share by Type (2016-2021)
Table 74. Global Botanical and Herbal Drug Revenue Forecast by Type (2021-2026)
Table 75. Global Botanical and Herbal Drug Revenue by Application (2016-2021)
Table 76. Global Botanical and Herbal Drug Revenue Forecast by Application (2021-2026)
Table 77. North America Botanical and Herbal Drug Revenue by Type (2016-2021) & (USD Million)
Table 78. North America Botanical and Herbal Drug Revenue by Type (2021-2026) & (USD Million)
Table 79. North America Botanical and Herbal Drug Revenue by Application (2016-2021) & (USD Million)
Table 80. North America Botanical and Herbal Drug Revenue by Application (2021-2026) & (USD Million)
Table 81. North America Botanical and Herbal Drug Revenue by Country (2016-2021) & (USD Million)
Table 82. North America Botanical and Herbal Drug Revenue by Country (2021-2026) & (USD Million)
Table 83. Europe Botanical and Herbal Drug Revenue by Type (2016-2021) & (USD Million)
Table 84. Europe Botanical and Herbal Drug Revenue by Type (2021-2026) & (USD Million)
Table 85. Europe Botanical and Herbal Drug Revenue by Application (2016-2021) & (USD Million)
Table 86. Europe Botanical and Herbal Drug Revenue by Application (2021-2026) & (USD Million)
Table 87. Europe Botanical and Herbal Drug Revenue by Country (2016-2021) & (USD Million)
Table 88. Europe Botanical and Herbal Drug Revenue by Country (2021-2026) & (USD Million)
Table 89. Asia-Pacific Botanical and Herbal Drug Revenue by Type (2016-2021) & (USD Million)
Table 90. Asia-Pacific Botanical and Herbal Drug Revenue by Type (2021-2026) & (USD Million)
Table 91. Asia-Pacific Botanical and Herbal Drug Revenue by Application (2016-2021) & (USD Million)
Table 92. Asia-Pacific Botanical and Herbal Drug Revenue by Application (2021-2026) & (USD Million)
Table 93. Asia-Pacific Botanical and Herbal Drug Revenue by Region (2016-2021) & (USD Million)
Table 94. Asia-Pacific Botanical and Herbal Drug Revenue by Region (2021-2026) & (USD Million)
Table 95. South America Botanical and Herbal Drug Revenue by Type (2016-2021) & (USD Million)
Table 96. South America Botanical and Herbal Drug Revenue by Type (2021-2026) & (USD Million)
Table 97. South America Botanical and Herbal Drug Revenue by Application (2016-2021) & (USD Million)
Table 98. South America Botanical and Herbal Drug Revenue by Application (2021-2026) & (USD Million)
Table 99. South America Botanical and Herbal Drug Revenue by Country (2016-2021) & (USD Million)
Table 100. South America Botanical and Herbal Drug Revenue by Country (2021-2026) & (USD Million)
Table 101. Middle East & Africa Botanical and Herbal Drug Revenue by Type (2016-2021) & (USD Million)
Table 102. Middle East & Africa Botanical and Herbal Drug Revenue by Type (2021-2026) & (USD Million)
Table 103. Middle East & Africa Botanical and Herbal Drug Revenue by Application (2016-2021) & (USD Million)
Table 104. Middle East & Africa Botanical and Herbal Drug Revenue by Application (2021-2026) & (USD Million)
Table 105. Middle East & Africa Botanical and Herbal Drug Revenue by Country (2016-2021) & (USD Million)
Table 106. Middle East & Africa Botanical and Herbal Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Botanical and Herbal Drug Picture
Figure 2. Global Botanical and Herbal Drug Revenue Market Share by Type in 2020
Figure 3. Prescription Drug
Figure 4. OTC
Figure 5. Botanical and Herbal Drug Revenue Market Share by Application in 2020
Figure 6. Cardiovascular Picture
Figure 7. Tumor Picture
Figure 8. Respiratory System Picture
Figure 9. Other Picture
Figure 10. Global Botanical and Herbal Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Botanical and Herbal Drug Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Botanical and Herbal Drug Revenue Market Share by Region (2016-2026)
Figure 13. Global Botanical and Herbal Drug Revenue Market Share by Region in 2020
Figure 14. North America Botanical and Herbal Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Botanical and Herbal Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Botanical and Herbal Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Botanical and Herbal Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Botanical and Herbal Drug Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Botanical and Herbal Drug Market Drivers
Figure 20. Botanical and Herbal Drug Market Restraints
Figure 21. Botanical and Herbal Drug Market Trends
Figure 22. Buchang Pharmaceuticals Recent Developments and Future Plans
Figure 23. China TCM Recent Developments and Future Plans
Figure 24. Tsumura Recent Developments and Future Plans
Figure 25. Schwabe Recent Developments and Future Plans
Figure 26. Tong Ren Tang Recent Developments and Future Plans
Figure 27. Jumpcan Pharmaceutical Recent Developments and Future Plans
Figure 28. Guangzhou Baiyunshan Pharmaceutical Recent Developments and Future Plans
Figure 29. Yunnan Baiyao Recent Developments and Future Plans
Figure 30. Tasly Holding Group Recent Developments and Future Plans
Figure 31. Bionorica Se Recent Developments and Future Plans
Figure 32. Huarun 999 Recent Developments and Future Plans
Figure 33. Taiji Recent Developments and Future Plans
Figure 34. Weleda Recent Developments and Future Plans
Figure 35. Kwangdong Recent Developments and Future Plans
Figure 36. GW Pharmaceuticals Recent Developments and Future Plans
Figure 37. Global Botanical and Herbal Drug Revenue Share by Players in 2020
Figure 38. Botanical and Herbal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Botanical and Herbal Drug Revenue Market Share in 2020
Figure 40. Global Top 10 Players Botanical and Herbal Drug Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Botanical and Herbal Drug Revenue Share by Type in 2020
Figure 43. Global Botanical and Herbal Drug Market Share Forecast by Type (2021-2026)
Figure 44. Global Botanical and Herbal Drug Revenue Share by Application in 2020
Figure 45. Global Botanical and Herbal Drug Market Share Forecast by Application (2021-2026)
Figure 46. North America Botanical and Herbal Drug Sales Market Share by Type (2016-2026)
Figure 47. North America Botanical and Herbal Drug Sales Market Share by Application (2016-2026)
Figure 48. North America Botanical and Herbal Drug Revenue Market Share by Country (2016-2026)
Figure 49. United States Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Botanical and Herbal Drug Sales Market Share by Type (2016-2026)
Figure 53. Europe Botanical and Herbal Drug Sales Market Share by Application (2016-2026)
Figure 54. Europe Botanical and Herbal Drug Revenue Market Share by Country (2016-2026)
Figure 55. Germany Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Botanical and Herbal Drug Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Botanical and Herbal Drug Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Botanical and Herbal Drug Revenue Market Share by Region (2016-2026)
Figure 63. China Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Botanical and Herbal Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Botanical and Herbal Drug Sales Market Share by Application (2016-2026)
Figure 71. South America Botanical and Herbal Drug Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Botanical and Herbal Drug Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Botanical and Herbal Drug Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Botanical and Herbal Drug Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Botanical and Herbal Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
  • Research Report on China's Mecapegfilgrastim Market, 2021-2025
    Published: 26-Nov-2021        Price: US 2600 Onwards        Pages: 40
    According to the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO), China reported about 4.57 million new cancer cases in 2020, around 3 million of which were dead. Cancer treatments include surgery, radiation therapy and chemotherapy. Radiation therapy is one of the treatments that involves the use of high-energy waves (such as X-rays) to kill cancer cells. Radiotherapy can be used alone or in combination with other treatments (systemic therapy, surgery, ......
  • Research Report on China's Anlotinib Hydrochloride Market, 2021-2025
    Published: 26-Nov-2021        Price: US 2600 Onwards        Pages: 40
    Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Its clinical trials are already underway for a variety of cancers, including non-small cell lung cancer, soft tissue sarcoma,......
  • Global and Japan Pets Anti-infective Drugs Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 105
    Global Pets Anti-infective Drugs Scope and Market Size Pets Anti-infective Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pets Anti-infective Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. S......
  • Global and Japan Fibroblast Growth Factor Receptor 2 Inhibitor Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 115
    Global Fibroblast Growth Factor Receptor 2 Inhibitor Scope and Market Size Fibroblast Growth Factor Receptor 2 Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibroblast Growth Factor Receptor 2 Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of rev......
  • Global and Japan FGF-2 Inhibitors Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 124
    Global FGF-2 Inhibitors Scope and Market Size FGF-2 Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global FGF-2 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - ASP......
  • Global and China Anlotinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 122
    Anlotinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anlotinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Anlotinib Drugs market si......
  • Global and Japan Osimertinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 121
    Osimertinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Osimertinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Osimertinib Drugs mar......
  • Global and China Regofinil Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 122
    Regofinil market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Regofinil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Regofinil market size by players, by ......
  • Global and Japan Alectinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 123
    Alectinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Alectinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Alectinib Drugs market si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs